Your browser doesn't support javascript.
loading
"Dark" Singlet Oxygen and Electron Paramagnetic Resonance Spin Trapping as Convenient Tools to Assess Photolytic Drug Degradation.
Persich, Peter; Hostyn, Steven; Joie, Céline; Winderickx, Guy; Pikkemaat, Jeroen; Romijn, Edwin P; Maes, Bert U W.
Afiliación
  • Persich P; Janssen R&D Pharmaceutical Development and Manufacturing Sciences, Beerse, Belgium. Electronic address: ppersich@its.jnj.com.
  • Hostyn S; Janssen R&D Pharmaceutical Development and Manufacturing Sciences, Beerse, Belgium.
  • Joie C; Janssen R&D Pharmaceutical Development and Manufacturing Sciences, Beerse, Belgium; Department of Chemistry-Organic Synthesis, University of Antwerp, Antwerp, Belgium.
  • Winderickx G; Janssen R&D Pharmaceutical Development and Manufacturing Sciences, Beerse, Belgium.
  • Pikkemaat J; Janssen R&D Pharmaceutical Development and Manufacturing Sciences, Beerse, Belgium.
  • Romijn EP; Janssen R&D Pharmaceutical Development and Manufacturing Sciences, Beerse, Belgium.
  • Maes BU; Department of Chemistry-Organic Synthesis, University of Antwerp, Antwerp, Belgium.
J Pharm Sci ; 106(5): 1310-1316, 2017 05.
Article en En | MEDLINE | ID: mdl-28108379
Forced degradation studies are an important tool for a systematic assessment of decomposition pathways and identification of reactive sites in active pharmaceutical ingredients (APIs). Two methodologies have been combined in order to provide a deeper understanding of singlet oxygen-related degradation pathways of APIs under light irradiation. First, we report that a "dark" singlet oxygen test enables the investigation of drug reactivity toward singlet oxygen independently of photolytic irradiation processes. Second, the photosensitizing properties of the API producing the singlet oxygen was proven and quantified by spin trapping and electron paramagnetic resonance analysis. A combination of these techniques is an interesting addition to the forced degradation portfolio as it can be used for (1) revealing unexpected degradation pathways of APIs due to singlet oxygen, (2) clarifying photolytic drug-drug interactions in fixed-dose combinations, and (3) synthesizing larger quantities of hardly accessible oxidative drug degradants.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fotólisis / Preparaciones Farmacéuticas / Detección de Spin / Oxígeno Singlete Idioma: En Revista: J Pharm Sci Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fotólisis / Preparaciones Farmacéuticas / Detección de Spin / Oxígeno Singlete Idioma: En Revista: J Pharm Sci Año: 2017 Tipo del documento: Article
...